Something positive, right, with that rising case count hitting new records, it seems virtually every day, and deaths also starting to move up in knows hardhit states as well with hospitalizations thats certainly been a focus for Market Participants as you guys well know Scott Gottlieb who we follow closely tweeting about the remdesivir news, very encouraged but needs to be confirmed in a prospective trial, appears to be a receipt peck testify analysis of the face three data suggesting a survival benefit in severe Covid Patients. We have made the point many times it is only good news on remdesivir, but lets remember its an infused therapy in the hospital typically for people who are severely ill what we are hoping for and waiting for are significant antivirals that will have an affect on the virus far earlier in its course so that people will feel much more comfortable in resuming behavior because if they were to get it and these were to be available they could immediately take an oral